PetVivo (PETVW) Competitors $0.04 0.00 (0.00%) As of 09/15/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock PETVW vs. DRTSW, ANZUW, ATAKW, BBLGW, HSCSW, BEATW, LUCYW, IINNW, NXGLW, and NVACWShould you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), Innovative Eyewear (LUCYW), Inspira Technologies Oxy B.H.N. (IINNW), NEXGEL (NXGLW), and NorthView Acquisition (NVACW). These companies are all part of the "medical equipment" industry. PetVivo vs. Its Competitors Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Heart Test Laboratories HeartBeam Innovative Eyewear Inspira Technologies Oxy B.H.N. NEXGEL NorthView Acquisition Alpha Tau Medical (NASDAQ:DRTSW) and PetVivo (NASDAQ:PETVW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Does the media favor DRTSW or PETVW? In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 1 articles in the media. Alpha Tau Medical's average media sentiment score of 1.91 beat PetVivo's score of 1.34 indicating that Alpha Tau Medical is being referred to more favorably in the media. Company Overall Sentiment Alpha Tau Medical Very Positive PetVivo Positive Which has stronger earnings and valuation, DRTSW or PETVW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Tau MedicalN/AN/AN/AN/AN/APetVivo$1.05MN/AN/AN/AN/A Is DRTSW or PETVW more profitable? Company Net Margins Return on Equity Return on Assets Alpha Tau MedicalN/A N/A N/A PetVivo N/A N/A N/A SummaryAlpha Tau Medical and PetVivo tied by winning 1 of the 2 factors compared between the two stocks. Get PetVivo News Delivered to You Automatically Sign up to receive the latest news and ratings for PETVW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PETVW vs. The Competition Export to ExcelMetricPetVivoMedical Devices IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.58B$5.70B$10.27BDividend YieldN/A2.45%5.72%4.60%P/E RatioN/A257.3675.8126.51Price / SalesN/A147.02492.95166.26Price / CashN/A15.9925.8129.90Price / BookN/A3.7412.836.31Net IncomeN/A$132.05M$3.28B$270.12M7 Day PerformanceN/A-1.11%0.24%2.04%1 Month PerformanceN/A-3.74%4.59%6.25%1 Year PerformanceN/A11.58%68.69%25.50% PetVivo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PETVWPetVivoN/A$0.04flatN/AN/A$0.00$1.05M0.0020Positive NewsDRTSWAlpha Tau MedicalN/A$0.30+0.7%N/AN/A$0.00N/A0.0080ANZUWAnzu Special Acquisition Corp IN/A$0.04+20.6%N/A-29.9%$0.00N/A0.002Gap UpATAKWAurora Technology AcquisitionN/A$0.02flatN/A-67.0%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$10.79-28.1%N/AN/A$0.00N/A0.002Positive NewsGap DownHSCSWHeart Test LaboratoriesN/A$0.06-21.0%N/AN/A$0.00$4.35K0.0010Positive NewsGap DownBEATWHeartBeamN/A$0.23-3.3%N/A-55.3%$0.00N/A0.005Positive NewsGap DownLUCYWInnovative EyewearN/A$0.06-33.1%N/A+240.3%$0.00$1.98M0.009Positive NewsGap DownIINNWInspira Technologies Oxy B.H.N.N/A$0.35+0.0%N/A+22.9%$0.00N/A0.0020Positive NewsGap DownNXGLWNEXGELN/A$0.31+6.6%N/AN/A$0.00$11.67M0.0010Positive NewsNVACWNorthView AcquisitionN/A$0.14flatN/AN/A$0.00N/A0.002 Related Companies and Tools Related Companies Alpha Tau Medical Competitors Anzu Special Acquisition Corp I Competitors Aurora Technology Acquisition Competitors Bone Biologics Competitors Heart Test Laboratories Competitors HeartBeam Competitors Innovative Eyewear Competitors Inspira Technologies Oxy B.H.N. Competitors NEXGEL Competitors NorthView Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PETVW) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetVivo Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PetVivo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.